Intrexon | XON - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Alaunos Therapeutics USD 7M 2M 2026-03
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 18.73B 660M 2026-03
Karyopharm Therapeutics USD 1.12B 989M 2026-07
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
MacroGenics USD 287M 103M 2026-07
MannKind USD 757M 984M 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Veracyte USD 2.57B 758M 2026-03
Xencor USD 893M 200M 2026-03